Annual Drug Patent Expirations for ROCKLATAN
Rocklatan is a drug marketed by Aerie Pharms Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.
This drug has fifty patent family members in eight countries.
The generic ingredient in ROCKLATAN is latanoprost; netarsudil dimesylate. One supplier is listed for this compound. Additional details are available on the latanoprost; netarsudil dimesylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
